Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
93 studies found for:    Open Studies | "Dermatitis, Atopic"
Show Display Options
Rank Status Study
1 Recruiting Effects of Treatments on Atopic Dermatitis
Conditions: Dermatitis, Atopic;   Human Volunteers;   Eczema;   Atopic Dermatitis
Interventions: Drug: Trimethoprim/sulfamethoxazole;   Drug: Cephalexin;   Drug: Doxycycline;   Other: Sodium hypochlorite (bleach)
2 Recruiting Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
Condition: Dermatitis, Atopic
Interventions: Drug: Fluticasone, cream;   Drug: Placebo,
3 Recruiting Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
Condition: Dermatitis, Atopic Dermatitis
Interventions: Drug: Apremilast;   Drug: Placebo
4 Recruiting Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
Condition: Dermatitis, Atopic
Interventions: Drug: AN2728 Topical Ointment, 2%;   Drug: Matching vehicle control
5 Recruiting Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
Condition: Dermatitis, Atopic
Interventions: Drug: AN2728 Topical Ointment, 2%;   Drug: Matching vehicle control
6 Recruiting Systemic Therapies for Pediatric Atopic Dermatitis
Condition: Dermatitis, Atopic
Intervention:
7 Recruiting Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
Conditions: Dermatitis, Atopic;   Eczema
Interventions: Drug: Desonide Cream;   Other: Amino Acid Moisturizing Cream
8 Not yet recruiting Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Condition: Dermatitis, Atopic
Interventions: Drug: dupilumab;   Drug: placebo
9 Not yet recruiting Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Condition: Dermatitis, Atopic
Interventions: Drug: dupilumab;   Drug: placebo
10 Recruiting Registry for the Atopic Dermatitis Research Network
Conditions: Atopic Dermatitis;   Eczema Herpeticum
Intervention:
11 Recruiting Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
Condition: Mild to Moderate Atopic Dermatitis
Interventions: Drug: SB011, 2 % (Water/Oil/Water) emulsion of hgd40;   Drug: Multiple W/O/W formulation, active ingredient-free vehicle
12 Recruiting S. Aureus Colonization in Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
13 Unknown  Common Allergens in Skin Tests for Adult Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
14 Unknown  Climatotherapy At The Dead Sea For Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
15 Recruiting Defining the Unique Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema
Intervention:
16 Unknown  Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
Condition: ATOPIC DERMATITIS
Intervention: Drug: A -1 Cool Cream,Vaselin ointment
17 Recruiting Bleach Bath Treatment of Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: bleach bath (sodium hypochlorite)
18 Unknown  Sublingual Immunotherapy in Patients With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: Dermatophagoides Farinae Drops Group 1;   Biological: Dermatophagoides Farinae Drops Group 2;   Biological: Dermatophagoides Farinae Drops Group 3;   Biological: Placebo
19 Recruiting Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients
Condition: Atopic Dermatitis
Interventions: Other: Placebo shower gel;   Other: Holly Mangrove Shower Gel
20 Recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years